- Article
Low Renalase Levels in Newly Diagnosed CML: Dysregulation Sensitive to Modulation by Tyrosine Kinase Inhibitors
- Jelena Milenkovic,
- Dijana Stojanovic,
- Sanja Velickovic,
- Branka Djordjevic,
- Goran Marjanovic and
- Maja Milojkovic
10 December 2024
Background: A dysregulated proinflammatory microenvironment is considered one of the reasons why current therapies of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors (TKI) do not secure disease control. Therefore, the development of BC...

